Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2016; 41(3): 342-345


Leptin as an early pregnancy marker for pregnancy induced hypertension

Huma Tasleem, Tasneem Akhter, Haider Ghazanfar, Samina Tasleem, Salman Assad.




Abstract

Objectives: To study the role of serum leptin as an early pregnancy marker for pre-eclampsia.
Methodology: A total of 1300 patients were selected for the study. 79 (6%) were lost to follow-up. Out of 1221 patients, 134 (10.9%) patients developed pre-eclampsia, 1087 (89.1%) remained normotensive. Patients included in the study had confirmed intrauterine pregnancy with ultrasound, either normotensive or ≥140/90 mmHg, 24-hour urine proteinuria >300mg or ratio of protein to creatinine >30mg/mmol. Patients with pre-eclampsia in the previous pregnancy and twin pregnancy were not included in the study. Blood samples were taken at the gestational age of 16 weeks and serum leptin level was measured by ELISA.
Result: Mean age of the pre-eclampsia group was 27.54±4.50 years and for the normal pregnancy group was 27.65±4.62 years. Mean leptin value in the pre-eclampsia group was 64.38±12.77ng/ml while in normal group it was 63.64±33.58 ng/ml (p>0.05). Cesarean rate was higher in the pre-eclampsia group (14.9%) as compared to normal pregnancy group (8.9%).
Conclusion: Serum leptin levels were found to be similar in the patients with preeclampsia and normotensive pregnant women.

Key words: Biomarkers, leptin, pre-eclampsia, proteinuria.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.